These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 8889502

  • 1. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW.
    Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
    [Abstract] [Full Text] [Related]

  • 2. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW.
    Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029
    [Abstract] [Full Text] [Related]

  • 3. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 4. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK.
    Cancer Res; 1995 May 15; 55(10):2150-7. PubMed ID: 7743516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1995 Jan 15; 55(2):224-7. PubMed ID: 7812948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1994 Mar 15; 54(6):1422-4. PubMed ID: 8137242
    [Abstract] [Full Text] [Related]

  • 11. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.
    Cancer Res; 1997 Mar 01; 57(5):907-12. PubMed ID: 9041193
    [Abstract] [Full Text] [Related]

  • 12. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C.
    Anticancer Res; 1999 Mar 01; 19(3A):1893-9. PubMed ID: 10470133
    [Abstract] [Full Text] [Related]

  • 13. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N, Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D, Simon B.
    Cancer Res; 2001 Aug 01; 61(15):5905-10. PubMed ID: 11479232
    [Abstract] [Full Text] [Related]

  • 14. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 01; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 15. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 01; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

  • 16. Evidence for two bladder cancer suppressor loci on human chromosome 9.
    Ruppert JM, Tokino K, Sidransky D.
    Cancer Res; 1993 Nov 01; 53(21):5093-5. PubMed ID: 8221642
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 20. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
    Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JC.
    Cancer Res; 1994 Aug 01; 54(15):4003-6. PubMed ID: 8033130
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.